How SARS-CoV-2 Transformed the Clinical Laboratory : Challenges and Lessons Learned
© American Association for Clinical Chemistry 2021. All rights reserved. For permissions, please email: journals.permissionsoup.com..
The COVID-19 pandemic has made a devastating impact on global health and continues to challenge healthcare infrastructure and delivery. The clinical laboratories were no exception as they are responsible for diagnostic testing that dictates many clinical, infection control, and public health decisions. Information technology and laboratory management tools are critical assets for maintaining and adapting operations in response to crises. When utilized effectively, they promote the integration between the clinical laboratory specialties (e.g., chemistry, hematology, microbiology, and molecular pathology). During the COVID-19 pandemic, our systems and processes were strained due to high testing volumes, demand for rapid turnaround times, supply chain constraints, and constantly evolving testing algorithms and result interpretations as our knowledge of the virus and of diagnostics increased over time. In this report, we describe those challenges and subsequent adaptations made by each clinical laboratory section. We hope these details help to provide potential solutions and approaches for other hospitals facing COVID-19 surges or other future pandemics.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:6 |
|---|---|
| Enthalten in: |
The journal of applied laboratory medicine - 6(2021), 5 vom: 01. Sept., Seite 1338-1354 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Tsai, Jonathan M [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
COVID-19 |
|---|
| Anmerkungen: |
Date Completed 15.10.2021 Date Revised 15.10.2021 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1093/jalm/jfab034 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM323782965 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM323782965 | ||
| 003 | DE-627 | ||
| 005 | 20231225184924.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/jalm/jfab034 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1079.xml |
| 035 | |a (DE-627)NLM323782965 | ||
| 035 | |a (NLM)33822967 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Tsai, Jonathan M |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a How SARS-CoV-2 Transformed the Clinical Laboratory |b Challenges and Lessons Learned |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 15.10.2021 | ||
| 500 | |a Date Revised 15.10.2021 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © American Association for Clinical Chemistry 2021. All rights reserved. For permissions, please email: journals.permissionsoup.com. | ||
| 520 | |a The COVID-19 pandemic has made a devastating impact on global health and continues to challenge healthcare infrastructure and delivery. The clinical laboratories were no exception as they are responsible for diagnostic testing that dictates many clinical, infection control, and public health decisions. Information technology and laboratory management tools are critical assets for maintaining and adapting operations in response to crises. When utilized effectively, they promote the integration between the clinical laboratory specialties (e.g., chemistry, hematology, microbiology, and molecular pathology). During the COVID-19 pandemic, our systems and processes were strained due to high testing volumes, demand for rapid turnaround times, supply chain constraints, and constantly evolving testing algorithms and result interpretations as our knowledge of the virus and of diagnostics increased over time. In this report, we describe those challenges and subsequent adaptations made by each clinical laboratory section. We hope these details help to provide potential solutions and approaches for other hospitals facing COVID-19 surges or other future pandemics | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a SARS-CoV-2 PCR testing | |
| 650 | 4 | |a clinical laboratory | |
| 650 | 4 | |a informatics | |
| 650 | 4 | |a laboratory management | |
| 650 | 4 | |a lessons learned | |
| 700 | 1 | |a Tolan, Nicole V |e verfasserin |4 aut | |
| 700 | 1 | |a Petrides, Athena K |e verfasserin |4 aut | |
| 700 | 1 | |a Kanjilal, Sanjat |e verfasserin |4 aut | |
| 700 | 1 | |a Brigl, Manfred |e verfasserin |4 aut | |
| 700 | 1 | |a Lindeman, Neal I |e verfasserin |4 aut | |
| 700 | 1 | |a Li, Yen-Der |e verfasserin |4 aut | |
| 700 | 1 | |a Tanasijevic, Milenko J |e verfasserin |4 aut | |
| 700 | 1 | |a Basu, Sankha S |e verfasserin |4 aut | |
| 700 | 1 | |a Melanson, Stacy E F |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The journal of applied laboratory medicine |d 2016 |g 6(2021), 5 vom: 01. Sept., Seite 1338-1354 |w (DE-627)NLM266162665 |x 2576-9456 |7 nnns |
| 773 | 1 | 8 | |g volume:6 |g year:2021 |g number:5 |g day:01 |g month:09 |g pages:1338-1354 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/jalm/jfab034 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 6 |j 2021 |e 5 |b 01 |c 09 |h 1338-1354 | ||